- Home
- SYTA vs QNRX Comparison
SYTA vs QNRX Comparison
Compare SYTA & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- QNRX
- Stock Information
- Founded
- SYTA N/A
- QNRX 2018
- Country
- SYTA Canada
- QNRX United States
- Employees
- SYTA N/A
- QNRX N/A
- Industry
- SYTA Telecommunications Equipment
- QNRX Medical/Dental Instruments
- Sector
- SYTA Telecommunications
- QNRX Health Care
- Exchange
- SYTA Nasdaq
- QNRX Nasdaq
- Market Cap
- SYTA 3.1M
- QNRX 2.7M
- IPO Year
- SYTA 2020
- QNRX N/A
- Fundamental
- Price
- SYTA $3.23
- QNRX $0.32
- Analyst Decision
- SYTA
- QNRX Strong Buy
- Analyst Count
- SYTA 0
- QNRX 1
- Target Price
- SYTA N/A
- QNRX $4.00
- AVG Volume (30 Days)
- SYTA 240.3K
- QNRX 4.1M
- Earning Date
- SYTA 04-07-2025
- QNRX 03-12-2025
- Dividend Yield
- SYTA N/A
- QNRX N/A
- EPS Growth
- SYTA N/A
- QNRX N/A
- EPS
- SYTA N/A
- QNRX N/A
- Revenue
- SYTA $11,988,979.00
- QNRX N/A
- Revenue This Year
- SYTA $75.92
- QNRX N/A
- Revenue Next Year
- SYTA $19.72
- QNRX N/A
- P/E Ratio
- SYTA N/A
- QNRX N/A
- Revenue Growth
- SYTA 41.59
- QNRX N/A
- 52 Week Low
- SYTA $3.04
- QNRX $0.28
- 52 Week High
- SYTA $885.60
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- SYTA 30.99
- QNRX 38.39
- Support Level
- SYTA $3.04
- QNRX $0.30
- Resistance Level
- SYTA $5.40
- QNRX $0.35
- Average True Range (ATR)
- SYTA 0.49
- QNRX 0.04
- MACD
- SYTA -0.06
- QNRX 0.01
- Stochastic Oscillator
- SYTA 8.05
- QNRX 17.24
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.